Arie Belldegrun

Arie Belldegrun, MD, serves on the Board of Directors for multiple organizations including ByHeart, Ginkgo Bioworks, and IconOVir Bio, and holds the position of Co-Chairman at Breakthrough Properties. In academia, Belldegrun is a Professor and Director of the UCLA Institute of Urologic Oncology and occupies the Doumani Chair in Urologic Oncology at UCLA Health System. As an entrepreneur, Belldegrun is the Executive Chairman and Co-Founder of Allogene Therapeutics, the Chairman of the Board at Kronos Bio, Inc., and a Chairman & Partner at Two River. Belldegrun is also the Co-Founder and Senior Managing Partner of Vida Ventures, LLC, and the Founder, Chairman, President, and CEO of Kite Pharma. Educational credentials include an MD from Hadassah Medical School, a residency in Urologic Surgery at Harvard Medical School, and Fellowships in Surgical Oncology at the National Cancer Institute/NIH.